insights_auto
Why is MANKIND down 3.07%?
Dive Deeperchevron_right
MANKIND:NSE
Mankind Pharma Ltd
₹ 2,275.50
arrow_downward
-3.07%(-72.10) 1D
10-р сарын 16, 15:30:00 (GMT+5:30) · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MANKIND...
Open
₹ 2,349.90
High
₹ 2,354.40
Low
₹ 2,268.70
Mkt. cap
937.40Т
Avg. vol.
483.95 мян
Volume
889.73 мян
P/E ratio
46.04
52-wk high
₹ 2,642.00
52-wk low
₹ 1,909.70
EPS
₹ 49.42
No. of employees
20 мян
Open
₹ 2,349.90
High
₹ 2,354.40
Low
₹ 2,268.70
Mkt. cap
937.40Т
Avg. vol.
483.95 мян
Volume
889.73 мян
P/E ratio
46.04
52-wk high
₹ 2,642.00
52-wk low
₹ 1,909.70
EPS
₹ 49.42
No. of employees
20 мян
News stories
From web sources and news partners
The Pharma Letter
·
1 цагийн өмнө
Lakefront sells CAR-T programs as Mankind agrees Armed Cell investment
Profile
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
About Mankind Pharma Ltd
CEORajeev Juneja | Sheetal Arora
Employees20.5 мян
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitemankindpharma.com